Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three NDORMS researchers have been awarded new titles in the University of Oxford's 2020 Recognition of Distinction exercise.

A montage of profile images of Richard Williams, Mark Coles and Dominic Furniss

The Recognition of Distinction reflects our staff's commitment to excellence in teaching and research. 

This year's recipients are - 

Mark Coles

PROFESSOR MARK COLES 

“It is a fantastic honour to have been awarded a Kennedy Professorship in Immunology in NDORMS. I am very excited about continuing to work with Arthritis – Therapy Acceleration Program and the underpinning research we are doing to discover and develop new therapeutics for rheumatoid arthritis, inflammatory disease and cancer using interdisciplinary approaches. As Director of Graduate studies I have had the privilege of supporting the Kennedy Trust Prize Studentship program, developing the next generation of scientists to tackle chronic inflammatory human disease.  I have recently become an official fellow and theme lead in cellular life at Reuben College, Oxford’s 39th and newest college which is dedicated to fostering interdisciplinary exchange in an inclusive, innovative and impact-oriented community to support graduate student development.”

 

Dominic Furniss

PROFESSOR DOMINIC FURNISS 

"I am delighted to have been awarded the title Professor of Plastic and Reconstructive Surgery in the recent University Recognition of Distinction awards. It is eight years since I joined NDORMS, and in that time I have had the privilege of working with some amazingly talented students, post-doctoral researchers, and collaborating with other brilliant PI's. This award really is recognition of the hard work of this excellent team, and the unwavering support I have had within NDORMS."  

 

Richard Williams

Professor Richard Williams 

"It was a great pleasure to receive the award and I am truly indebted to everyone who helped me to reach this goal. The support and mentorship provided by Profs Sir Marc Feldmann and Sir Tiny Maini has been especially important in my career and I look forward to celebrating with them and the rest of my colleagues during happier times." 

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research Trauma

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.